Inotiv Inc operates within the life sciences industry, specifically focusing on drug development and bioanalytical services. Its offerings are structured into two main segments: Pharmaceutical Development Services (PDS) and Bioanalytical Services (BAS). Below is a comprehensive overview of each segment, product, and service that Inotiv Inc provides.
Segments
1. Pharmaceutical Development Services (PDS) Inotiv’s PDS segment caters to pharmaceutical, biotechnology, and medical device industries by providing an extensive suite of research services tailored to the drug development lifecycle. The services in this segment encompass:
- Drug Discovery: This covers early-phase research activities essential for identifying and validating drug targets. Inotiv provides access to technologies for in vitro and in vivo testing, which are critical in evaluating potential drug candidates.
- Drug Development: Services here include the progression of promising compounds through the developmental pipeline. This involves formulation development, scale-up, and preclinical and clinical testing necessary to ensure product viability and safety.
- Bioanalysis: Utilized to measure drug concentration, systemic exposure, and the pharmacokinetic profile of drug candidates through advanced analytical techniques.
- Metabolism and Pharmacokinetics: Inotiv conducts studies aimed at understanding how drugs are metabolized in the body, including absorption, distribution, metabolism, and excretion (ADME).
- Toxicology: This involves comprehensive safety assessments including acute and chronic toxicity testing, as well as specialized toxicology assessments focusing on potential side effects of drug candidates.
- Pathology: Services provided within pathology include detailed examinations of tissues and organs through necropsy, histopathology, and safety pathology.
The PDS segments emphasis on customized solutions enables clients to address complex challenges throughout the drug development process.
Bioanalytical Services (BAS) Focusing on the analytical aspect, the BAS segment offers specialized services to measure and analyze biological and chemical compounds. Key components of this segment include:
- Bioanalysis: This includes a spectrum of techniques such as chromatography and mass spectrometry to measure drug levels and metabolites in biological samples.
- Biomarker Analysis: The identification and quantification of biomarkers are vital for understanding disease mechanisms and treatment efficacy, contributing to drug development and regulatory submissions.
- Pharmacokinetic Analysis: Inotiv provides services to assess drug performance in terms of concentration-time profiles and the implications for dosing regimens.
- ADME Studies: Studies designed to evaluate the absorption, distribution, metabolism, and excretion characteristics of drug candidates to ensure proper formulation and delivery.
- Data Management and Statistical Analysis: These services support clients in the interpretation and regulatory reporting of complex data sets generated throughout the analytical process.
Products
Inotiv Inc manufactures and markets a variety of products that enhance the capabilities of its PDS and BAS segments:
1. Drug Discovery Services This encompasses a suite of products including various in vitro and in vivo testing systems, assays for target validation, and early-stage compound profiling tools, all aimed at facilitating the drug discovery process.
Bioanalytical Services The company provides an array of bioanalytical tools and services, including:
- Chromatography and Mass Spectrometry: Essential equipment and solutions for quantitative analysis of drugs and biomarkers. - Immunoassays: Technologies used to quantitatively measure antigens or antibodies, vital for clinical trials.
Inotiv Software Inotiv has developed proprietary software platforms that assist pharmaceutical companies with data management, enhancing the accuracy of statistical analysis, and ensuring quality control throughout the research process.
Services
The range of services offered by Inotiv across its PDS and BAS segments is designed to meet the varied needs of its clients:
1. Drug Development Services These include comprehensive offerings such as detailed preclinical and clinical testing, as well as non-clinical safety assessments to support drug approval processes.
Bioanalysis Services Focusing on pharmacokinetic analysis, metabolite identification, and bioequivalence studies, these services enable a deeper understanding of how drugs behave in biological systems.
Toxicology Services Inotiv’s toxicology offerings cover extensive safety evaluation protocols, including assessments for acute and chronic toxicity, safety pharmacology, and genotoxicity testing.
Pathology Services With a strong emphasis on detailed pathology assessments, Inotiv provides services that span necropsy examinations, toxicologic pathology, and professional peer review to ensure the highest standard of analysis.
Regulatory Support Services Inotiv assists clients in navigating the regulatory environment associated with drug development. This involves consulting services for regulatory strategy, submission support for Investigational New Drug (IND) and New Drug Applications (NDA), and preparation for FDA audits.
Overall, Inotiv Inc positions itself as a comprehensive partner in pharmaceutical research and development, offering a well-rounded suite of services and products aimed at expediting drug discovery, improving safety assessments, and enhancing bioanalytical capabilities—all crucial for bringing innovative therapies to market efficiently.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
-2.9 %